Quantitative analysis for DBV Technologies S.A. (DBVT) — Health Care: AI-powered alpha score, Benjamin Graham intrinsic value, ML-based forecast, technical and fundamental signals, and insider activity.
Current Q-Score verdict: Strong Sell (5.0) (grade F). 28 signals analyzed (23 differentiated alt-data).
DBVT stock price is tracked daily for technical and fundamental analysis. The data below shows recent trading activity used in trend analysis, momentum calculation, and entry/exit signals.
| Date | High | Low | Close |
|---|---|---|---|
| 2026-04-28 | $21.05 | $20.57 | $20.80 |
| 2026-05-08 | $19.91 | $19.65 | $19.73 |
| 2026-05-20 | $18.90 | $18.37 | $18.54 |
| 2026-06-02 | $18.33 | $17.40 | $18.23 |
| 2026-06-12 | $17.73 | $16.37 | $17.42 |
| 2026-06-25 | $16.72 | $15.87 | $16.02 |
| 2026-07-08 | $17.43 | $16.27 | $16.75 |
| 2026-07-20 | $14.61 | $14.02 | $14.57 |
| 2026-07-30 | $14.05 | $13.45 | $13.81 |
| 2026-08-12 | $14.40 | $14.08 | $14.14 |
| 2026-08-24 | $14.32 | $13.99 | $14.14 |
| 2026-09-03 | $13.90 | $13.44 | $13.70 |
How DBV Technologies S.A. stacks up against same-sector peers on market capitalization and alpha scores:
| Ticker | Company | Market Cap | Alpha Score |
|---|---|---|---|
| CGC | Canopy Growth Corporation | $439M | — |
| AUTL | Autolus Therapeutics plc | $431M | 44.0 |
| OCGN | Ocugen, Inc. | $460M | — |
| ASMB | Assembly Biosciences, Inc. | $417M | — |
View all Health Care stocks by valuation and signals →
DBV Technologies S.A. (DBVT) scores Strong Sell (5.0), and the composite conceals a 90-point disagreement between its dimensions. It is strongest on analyst consensus at 94, and weakest on technicals at 5 and competitive moat at 4. A stock can carry analyst consensus that high while competitive moat sits at 4; the composite averages that tension away, which is why the breakdown is worth reading before the headline number. See Q-Score methodology for how these dimensions are weighted and combined.
| Dimension | Score |
|---|---|
| analyst consensus | 94 |
| technicals | 5 |
| competitive moat | 4 |
StoQuant analyzes 28 signals (23 alt-data). Alternative data sources (FDA approvals, GitHub activity, SEC filings, App Store ratings) complement traditional financial metrics.
All StoQuant signals are explained in our knowledge base:
Health Care Hub — Top performers and valuation outliers in Health Care
Get daily updates on DBV Technologies S.A. (DBVT): Q-Score changes, insider transactions, forecast shifts, sector rotation, and macroeconomic context. The StoQuant digest curates the most material signals for your watchlist — free, no account required.
See a sample digest • Unsubscribe anytime • Privacy policy
StoQuant is a quantitative stock research platform powered by AI scoring, fundamental analysis, and institutional-grade signals. We cover 3,600+ US-listed equities with daily updates on valuations, earnings quality, insider flow, and ML-based return forecasts. Learn more about us.
Share this stock's latest Q-Score and alpha score on your website, GitHub README, or blog. The SVG badge auto-updates daily:
<a href="https://stoquant.com/research/DBVT"><img src="https://stoquant.com/badge/DBVT.svg" alt="DBV Technologies S.A. (DBVT) Q-Score and Alpha on StoQuant" width="240" height="64" /></a>
StoQuant research is generated algorithmically using public market data, SEC filings, news feeds, and proprietary ML models. Not investment advice. Past performance does not guarantee future results.
Weekly Q-Score signals and insider buying activity on our highest-conviction stock picks. Email only, no account needed. See a sample digest.